Bladder Pain – Pipeline Review, 2019

Bladder refers to the balloon-shaped hollow muscles situated in the middle of the pelvis, which gets expanded when it is filled with urine and contracted when it gets empty. Bladder pain can affect both males and females due to various reasons. Urinary tract infections are the major reasons for bladder pain. In certain chronic cases, long term bladder pain can be due to Interstitial Cystitis (IC) or Bladder Pain Syndrome (BPS). Common symptoms of bladder pain syndrome include mild to severe pain, the urgency to urinate, increased urination frequency, and others.

Current treatment of bladder pain includes surgery and medication. Drugs like pentosan polysulfate sodium, antihistamine hydroxyzine, antidepressant amitriptyline, and others are commonly used for the treatment of bladder pain. Minimal invasive surgical procedures such as bladder instillation, bladder distention, and others are performed for the treatment of bladder pain.

Limited treatment options and rising prevalence of bladder pain has increased the number of a clinical study for bladder pain treatment. Various pharmaceutical companies and research institutes have been focusing on studying and developing new treatment options for bladder pain. For instance; ASP6294, which is being studied by Astellas Pharma Inc., is currently in phase 2 clinical trials for the treatment of bladder pain.

At present, around 47% of the pipeline candidates for bladder pain are in phase 2 clinical stage. More than half of the studies are sponsored by research institutes.

Report Description

The report on ‘Bladder Pain – Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for Bladder Pain. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for Bladder Pain.

The report on ‘Bladder Pain – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.

Report Scope

• Thorough assessment of the pipeline products by areas such as development stage; route of administration; drug class; indication; sponsor; molecule type and drug target


• Comprehensive profiles of the pipeline products with details such as company overview; product description; R&D status; development activities; mechanism of action; molecule type; development stage; indications; funding and route of administration


• Overview of dormant and discontinued pipeline products


• Key insights in relation to the epidemiology of conditions being treated by the pipeline products and overview of the addressable or current market for the pipeline products


• Overview of the latest developments; news articles, press releases and relevant conferences

Report Methodology

• All pipeline reports are built through the analysis of data primarily collected through credible desk research sources. Secondary research is supplemented by interviews conducted with key opinion leaders.


• Desk research sources includes global and regional clinical trials databases; annual reports, websites, press releases & investor presentations of companies; white papers; news articles; reports published by industry associations; articles/reports published on databases such as NCBI, ResearchGate; internal databases

Reasons to Buy this Report

• Develop effective growth strategies based on comprehensive overview of the R&D activity and pipeline products for Bladder Pain


• Identify emerging players or competition in the market based on pipeline products and develop strategies to counter the emergence of these players


• Identify the focus of leading players in relation to R&D for Bladder Pain


• Identify potential companies from a partnership or acquisition point of view based on current synergy in R&D activities or strategies to diversify R&D focus to drive growth in business


• Analyse the reasons behind dormant and discontinued products to make changes in the R&D focus if necessary